• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • LASIK
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

Alden acquires Fluoresoft, launches new practice finder tool

Article

Alden Optical recently acquired Fluoresoft, the only high molecular weight fluorescent solution available in the U.S., from Holles Laboratories, Inc.

Lancaster, NY-Alden Optical recently acquired Fluoresoft, the only high molecular weight fluorescent solution available in the U.S., from Holles Laboratories, Inc. The solution can be used to evaluate the cornea-to-lens fitting relationship, assess epithelial abnormalities due to contact lens wear, and assist during applanation tonometry. Fluoresoft’s high molecular weight compound prevents absorption by soft lens materials, preventing lens staining, according to the company.

In related news, Alden launched the Astera Multifocal Toric Practice Locator Tool. The map tool allows patients to locate practices offering the Astera Multifocal Toric lenses, which the company says is ideal for patients with astigmatism who don’t want to give up soft contact lenses as they become presyopic. 

Related Videos
R Tracy Williams, OD, FAAO, details his experience as a sports team optometrist
Andy Morgenstern, OD, FAAO, FNAP chats with Optometry Times
R Tracy Williams, OD, FAAO with Optometry Times
Shan Lin, MD, speaks on Glaucoma 360 presentation in an interview with Ophthalmology Times
Cecelia Koetting, OD, FAAO, DIPABO, left, speaks with Optometry Times about the 2024 EnVision Summit
Bonnie An Henderson, MD, highlights key takeaways of the 2024 EnVision Summit, including diversity and family inclusion
© 2024 MJH Life Sciences

All rights reserved.